HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yuka Sasaki Selected Research
Yuka Sasaki Research Topics
Disease
23
Neoplasms (Cancer)
05/2022 - 05/2005
21
Tuberculosis (Tuberculoses)
10/2020 - 08/2002
10
Pulmonary Tuberculosis
10/2020 - 12/2003
9
Infections
05/2022 - 07/2004
7
Carcinogenesis
03/2021 - 05/2005
6
Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
07/2019 - 08/2003
5
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 11/2016
4
Disease Progression
01/2020 - 07/2008
3
Lung Neoplasms (Lung Cancer)
05/2022 - 01/2019
3
Lung Diseases (Lung Disease)
01/2020 - 11/2016
2
Anorexia
04/2022 - 01/2012
2
Nausea
04/2022 - 01/2017
2
Melanoma (Melanoma, Malignant)
03/2022 - 02/2018
2
Pain (Aches)
10/2021 - 11/2015
2
Pleurisy (Pleuritis)
09/2019 - 07/2008
2
Interstitial Lung Diseases (Interstitial Lung Disease)
05/2018 - 02/2018
2
Alzheimer Disease (Alzheimer's Disease)
05/2017 - 08/2012
2
Colorectal Neoplasms (Colorectal Cancer)
09/2015 - 01/2012
2
Carcinoma (Carcinomatosis)
01/2014 - 05/2004
2
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2004 - 06/2003
1
Pancreatic Neoplasms (Pancreatic Cancer)
05/2022
1
Cachexia
04/2022
1
Aneuploidy (Aneuploid)
03/2022
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2022
1
Communicable Diseases (Infectious Diseases)
03/2022
1
Pulmonary Aspergillosis
03/2022
1
Aspergillosis
02/2022
1
Urinary Bladder Neoplasms (Bladder Cancer)
01/2022
1
Hemorrhagic Cystitis
10/2021
1
Autoimmune Diseases (Autoimmune Disease)
10/2021
1
Inflammation (Inflammations)
10/2021
1
Cystitis
10/2021
1
Stomach Neoplasms (Stomach Cancer)
08/2021
1
Experimental Melanoma
07/2021
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2021
Drug/Important Bio-Agent (IBA)
5
DNA (Deoxyribonucleic Acid)
IBA
02/2022 - 05/2005
5
Pharmaceutical Preparations
IBA
10/2021 - 05/2008
5
Prostaglandin-E Synthases
IBA
03/2021 - 12/2009
4
Biomarkers (Surrogate Marker)
IBA
03/2022 - 01/2019
4
Monoclonal Antibodies
IBA
08/2021 - 05/2005
4
Enzymes
IBA
03/2021 - 05/2008
4
prostacyclin synthetase (prostacyclin synthase)
IBA
01/2021 - 11/2015
3
Cisplatin (Platino)
FDA Link
Generic
04/2022 - 01/2019
3
Antigens
IBA
07/2021 - 07/2004
3
Dinoprostone (PGE2)
FDA Link
03/2021 - 12/2009
3
Macrolides
IBA
01/2020 - 11/2016
3
Antibodies
IBA
01/2020 - 01/2018
3
Vaccines
IBA
01/2020 - 03/2006
3
Rifampin (Rifampicin)
FDA Link
Generic
05/2017 - 07/2008
3
Gold
IBA
01/2016 - 05/2008
3
Interferons
IBA
01/2014 - 08/2004
3
Isoniazid (Ftivazide)
FDA Link
Generic
09/2011 - 05/2008
3
Acids
IBA
07/2008 - 08/2002
2
Small Interfering RNA (siRNA)
IBA
05/2022 - 01/2019
2
Poly(ADP-ribose) Polymerase Inhibitors
IBA
05/2022 - 03/2022
2
Proteins (Proteins, Gene)
FDA Link
10/2021 - 01/2014
2
Prostaglandins
IBA
03/2021 - 09/2015
2
Therapeutic Uses
IBA
04/2020 - 05/2018
2
Immunoglobulin A (IgA)
IBA
01/2020 - 09/2019
2
Immunoglobulin G (IgG)
IBA
01/2019 - 03/2006
2
Immunoglobulins (Immunoglobulin)
IBA
01/2018 - 03/2006
2
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
11/2015 - 09/2015
2
Tuberculin (PPD)
IBA
09/2010 - 07/2004
2
Pyrazinamide
FDA Link
Generic
07/2008 - 08/2003
2
Steroids
IBA
07/2008 - 11/2006
1
APOBEC-1 Deaminase
IBA
05/2022
1
Cytidine Deaminase
IBA
05/2022
1
olaparib
IBA
05/2022
1
Vinorelbine (Navelbine)
FDA Link
Generic
04/2022
1
Antineoplastic Agents (Antineoplastics)
IBA
04/2022
1
Creatinine
IBA
04/2022
1
pembrolizumab
IBA
04/2022
1
3-aminobenzamide
IBA
03/2022
1
HMGB1 Protein (HMG1)
IBA
03/2022
1
Immunoglobulin E (IgE)
IBA
03/2022
1
Plasminogen Activator Inhibitor 1
IBA
01/2022
1
Chromatin
IBA
01/2022
1
(2-(4-(4-isopropoxybenzyl)-phenylamino) imidazoline)
IBA
10/2021
1
Epoprostenol (Prostacyclin)
FDA Link
Generic
10/2021
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2021
1
Chemokines
IBA
10/2021
1
Acrolein (Aqualin)
IBA
10/2021
1
Protein Isoforms (Isoforms)
IBA
08/2021
1
Conditioned Culture Media
IBA
07/2021
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
07/2021
1
lamellarin 14
IBA
05/2021
1
anthracene
IBA
03/2021
1
pegfilgrastim (Neulasta)
FDA Link
03/2021
1
amrubicin
IBA
03/2021
Therapy/Procedure
13
Therapeutics
05/2022 - 07/2008
8
Drug Therapy (Chemotherapy)
04/2022 - 07/2005
2
Radiotherapy
07/2021 - 01/2011
2
Duration of Therapy
01/2020 - 08/2003
2
Chemoprevention
09/2015 - 10/2005
2
Retreatment
12/2009 - 12/2003
2
Gastrectomy
05/2006 - 05/2004
1
Adjuvant Chemotherapy
04/2022
1
Nuclear Reactors
03/2022
1
Boron Neutron Capture Therapy
03/2022
1
Immunotherapy
07/2021